Oriola operates in the Finnish and Swedish health and wellbeing markets

Oriola serves the health and wellbeing market with modern and customer-focused products and services, and connects all actors within the field, from pharmaceutical companies to pharmacies and consumers.

Interim Report Q1 2024

Oriola will publish its Interim Report for January-March 2024 on Thursday 25 April 2024 at around 8.30 a.m. Welcome to join our results presentation as a live webcast at 10 a.m. on the same day.

Annual Report 2023

Our Annual Report consists of the following sections: Business review, Sustainability report, Corporate governance statement, Remuneration report, Report of the Board of Directors and Financial statements.

Annual General Meeting 2023

Oriola's AGM was held on 19 March 2024. Thank you to all shareholders who participated at the AGM.